Robert C, Grob JJ, Schadendorf D, et al. Outcomes and characteristics of patients (pts) who achieved a complete response (CR) with combination dabrafenib and trametinib (D+T). SMR 2017, abstract 09-3.
128.000 nieuwe kankerpatiënten in 2023: meer diagnoses in vroeg stadium
feb 2024 | Borstkanker, Dermato-oncologie, Gynaecologische oncologie, Hoofd-halsoncologie, Longoncologie, Maag-darm-leveroncologie, Uro-oncologie